-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2022 to Q2 2025.
- Sonnet BioTherapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2025 was 3,965,220, a 530% increase year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 655,240, a 405% increase from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 129,760, a 34% decline from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)